Please login to the form below

Not currently logged in
Email:
Password:

pill formulation

This page shows the latest pill formulation news and features for those working in and with pharma, biotech and healthcare.

Maintenance OK boosts AstraZeneca’s Lynparza in Europe

Maintenance OK boosts AstraZeneca’s Lynparza in Europe

New pill formulation also helps AZ and MSD against competitors in PARP class. ... green light for a new tablet formulation that reduces the pill burden compared to the earlier capsule version.

Latest news

  • The problem with pills The problem with pills

    Conventional solid dosage forms have failed to keep pace with modern consumers’ evolving demands

  • FDA clears Boehringer’s once-daily HIV pill

    The US Food and Drug Administration has granted marketing approval for Boehringer Ingelheim's Viramune XR extended-release tablets, a one-pill, once-daily formulation of the HIV drug Viramune. ... The US Food and Drug Administration (FDA) has granted

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...
How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...